Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hecker

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Synthesis and biological evaluation of novel indoloazepine derivatives as non-peptide vasopressin V2 receptor antagonistsJay M Matthews, Michael N Greco, Leonard R Hecker, et al.
Veterinary Immunology and Immunopathology|January 25, 2003
Biological activity of immunostimulatory CpG DNA motifs in domestic animalsG Mutwiri, R Pontarollo, S Babiuk, et al.
Journal of Medicinal Chemistry|March 18, 2005
In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug designMichael J Costanzo, Harold R Almond, Leonard R Hecker, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3Han-Cheng Zhang, Hong Ye, Bruce R Conway, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Potent nonpeptide vasopressin receptor antagonists based on oxazino- and thiazinobenzodiazepine templatesJay M Matthews, William J Hoekstra, Alexey B Dyatkin, et al.
Journal of Medicinal Chemistry|December 22, 1999
Potent, orally active GPIIb/IIIa antagonists containing a nipecotic acid subunit. Structure-activity studies leading to the discovery of RWJ-53308W J Hoekstra, B E Maryanoff, B P Damiano, et al.
Journal of Medicinal Chemistry|March 18, 2005
Novel indolylindazolylmaleimides as inhibitors of protein kinase C-beta: synthesis, biological activity, and cardiovascular safetyHan-Cheng Zhang, Claudia K Derian, David F McComsey, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Synthesis and biological evaluation of novel indoloazepine derivatives as non-peptide vasopressin V2 receptor antagonistsJay M Matthews, Michael N Greco, Leonard R Hecker, et al.
Veterinary Immunology and Immunopathology|January 25, 2003
Biological activity of immunostimulatory CpG DNA motifs in domestic animalsG Mutwiri, R Pontarollo, S Babiuk, et al.
Journal of Medicinal Chemistry|March 18, 2005
In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug designMichael J Costanzo, Harold R Almond, Leonard R Hecker, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3Han-Cheng Zhang, Hong Ye, Bruce R Conway, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Potent nonpeptide vasopressin receptor antagonists based on oxazino- and thiazinobenzodiazepine templatesJay M Matthews, William J Hoekstra, Alexey B Dyatkin, et al.
Journal of Medicinal Chemistry|December 22, 1999
Potent, orally active GPIIb/IIIa antagonists containing a nipecotic acid subunit. Structure-activity studies leading to the discovery of RWJ-53308W J Hoekstra, B E Maryanoff, B P Damiano, et al.
Journal of Medicinal Chemistry|March 18, 2005
Novel indolylindazolylmaleimides as inhibitors of protein kinase C-beta: synthesis, biological activity, and cardiovascular safetyHan-Cheng Zhang, Claudia K Derian, David F McComsey, et al.
Pageof 11